P/E ratio for Nektar Therapeutics (NKTR)
P/E ratio as of April 2024 (TTM): -0.8037
According to Nektar Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.803681. At the end of 2022 the company had a P/E ratio of -1.15.
P/E ratio history for Nektar Therapeutics from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -1.15 | -75.71% |
| 2021 | -4.72 | -30.81% |
| 2020 | -6.83 | -20.31% |
| 2019 | -8.57 | -202.69% |
| 2018 | 8.34 | -108.8% |
| 2017 | -94.8 | 749.82% |
| 2016 | -11.2 | -60.28% |
| 2015 | -28.1 | -22.09% |
| 2014 | -36.0 | 344.63% |
| 2013 | -8.11 | 64.11% |
| 2012 | -4.94 | 4.98% |
| 2011 | -4.71 | -84.99% |
| 2010 | -31.3 | 273.27% |
| 2009 | -8.40 | -44.12% |
| 2008 | -15.0 | -19.38% |
| 2007 | -18.6 | 112% |
| 2006 | -8.79 | 15.37% |
| 2005 | -7.62 | -48.42% |
| 2004 | -14.8 | -8.82% |
| 2003 | -16.2 | 289.02% |
| 2002 | -4.16 | 7.1% |
| 2001 | -3.89 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 10.4 | -1,390.89% | 🇺🇸 USA |
 Pfizer PFE | 13.7 | -1,798.50% | 🇺🇸 USA |
 Amgen AMGN | 19.1 | -2,474.06% | 🇺🇸 USA |
 Baxter BAX | 7.85 | -1,076.22% | 🇺🇸 USA |
 Merck MRK | 72.0 | -9,060.76% | 🇺🇸 USA |
 AstraZeneca AZN | 37.9 | -4,811.94% | 🇬🇧 UK |
 Richardson Electronics RELL | 8.06 | -1,103.45% | 🇺🇸 USA |
 Alkermes ALKS | 19.0 | -2,460.77% | 🇮🇪 Ireland |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.